ConjuChem, LLC is a privately biotechnology company with a corporate office located in Los Angeles, California. ConjuChem is owned by NantWorks, LLC. ConjuChem creates novel, next-generation medicines using unique, long-acting therapeutic peptides. Underlying all ConjuChem compounds are bioconjugation platforms called Drug Affinity Complex (DACâ„¢) and Preformed Conjugate-Drug Affinity Complex (PC-DACâ„¢). When applied to a given peptide, DACâ„¢ and PC- DACâ„¢ can create new drugs with similar therapeutic activities but with significantly longer durations of activity and improved safety profiles.
View Top Employees from ConjuChem| Website | http://www.conjuchem.com |
| Revenue | $6 million |
| Employees | 4 (3 on RocketReach) |
| Founded | 1997 |
| Phone | (424) 208-7025 |
| Industry | Biotechnology, Pharmaceuticals, Biotechnology Research, Healthcare, Science and Engineering, Drug Manufacturing & Research |
| Competitors | Bellus Health, CeNeRx BioPharma, Centrose LLC, MyoKardia, PepGen |
| SIC | SIC Code 87 Companies, SIC Code 873 Companies |
| NAICS | NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 541 Companies, NAICS Code 541714 Companies, NAICS Code 5417 Companies |
Looking for a particular ConjuChem employee's phone or email?
ConjuChem Questions
The ConjuChem annual revenue was $6 million in 2023.
Karen Thibaudeau is the Senior Director, R and D of ConjuChem.
3 people are employed at ConjuChem.
The NAICS codes for ConjuChem are [54171, 54, 541, 541714, 5417].
The SIC codes for ConjuChem are [87, 873].
Top ConjuChem Employees
Related Companies
